<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 08 Nov 2009 19:56:54 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Biostar Raises $3.6 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</guid>
      <description><![CDATA[Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614366>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:26:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSPM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</link>
    </item>
    <item>
      <title>Bulls Back On Track?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</guid>
      <description><![CDATA[Good morning. With chants of &quot;Dow 10K… Dow 10K&quot; once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614255>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 16:21:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</link>
    </item>
    <item>
      <title>Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</guid>
      <description><![CDATA[Ford's 2,215 page 2007 master contract with the UAW 
1941 UAW-Ford contract<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614051>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 13:52:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</link>
    </item>
    <item>
      <title>Your Kind of Day?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</guid>
      <description><![CDATA[As a rule, I try not to read too terribly much into a &quot;Fed Day&quot; as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on &quot;Fed Days.&quot; But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611831>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:06:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</link>
    </item>
    <item>
      <title>The Dollar-Proof Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</guid>
      <description><![CDATA[Don't put off this important piece of the financial-planning process.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611744>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:31:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STPZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</link>
    </item>
    <item>
      <title>What Investors Should Look for In Today’s Fed Statement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</guid>
      <description><![CDATA[In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605772>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 13:04:24 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ING</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</link>
    </item>
    <item>
      <title>Are Discount Brokers Shares Worth Owning?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</guid>
      <description><![CDATA[The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&amp;P gain 15%.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3604683>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 01:28:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMTD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCHB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</link>
    </item>
    <item>
      <title>Technology Rises And Buying Facebook</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</guid>
      <description><![CDATA[Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%.&#160;&#160; Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601987>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:54:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</link>
    </item>
    <item>
      <title>Buffett Gets His Cheque Book Out</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</guid>
      <description><![CDATA[Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601899>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:17:34 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</link>
    </item>
    <item>
      <title>Five Ways To Ride The Commodities Bull</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</guid>
      <description><![CDATA[Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over.
Don’t believe it.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601726>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 15:21:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</link>
    </item>
    <item>
      <title>Personalized Anti-Cancer Vaccine, BiovaxID®, Targeting B-cell Lymphomas Available in Europe on a Named-Patient Basis</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3317923</guid>
      <description><![CDATA[Biovest International, Inc. (Other OTC:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (Other OTC:ABPIQ), today announced that BiovaxID&#174;, Biovest’s personalized therapeutic anti-cancer vaccine, is available on a named-patient (compassionate-use) basis in Europe. Following compliance with local regulatory protocols, BiovaxID will be supplied by idis Limited to European healthcare professionals for the treatment of follicular non-Hodgkin’s lymphoma and potentially for other B-cell blood cancers such as chronic lymphocytic leukemia, mantle cell lymphoma and multiple myeloma. Physicians in non-European countries may also contact idis to inquire about the potential availability of BiovaxID, as idis manages named-patient programs in more than 100 countries.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3317923>[More...]</a>]]></description>
      <pubDate>Sun, 28 Jun 2009 11:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPIQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3317923</link>
    </item>
    <item>
      <title>Biovest International Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize its Drugs and Technologies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2783381</guid>
      <description><![CDATA[Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (Other OTC:ABPI), today announced that, primarily due to the disruption in the U.S. capital and finance markets which limited access to required funding, the Company has filed a voluntary petition for reorganization. With existing cash flow and the potential for relatively near-term significant business development opportunities for BiovaxID&#174; and AutovaxID™, this action is intended to provide an opportunity for the Company to restore shareholder value and to pay all secured and unsecured creditors. Under protection of the court, Biovest plans to implement a series of initiatives designed to significantly decrease operating expenses and financing costs, and focus cash and resources on its priority programs that will allow the Company to attract key funding/partnering opportunities. Affiliates of the Company, including Hopkins Capital Group, LLC, a major shareholder, have indicated a willingness to provide additional financing to the Company as part of its reorganization plan. A conference call and webcast is scheduled for 4:30 p.m. (EST) this afternoon to further discuss this action.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2783381>[More...]</a>]]></description>
      <pubDate>Mon, 10 Nov 2008 15:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2783381</link>
    </item>
    <item>
      <title>Accentia Biopharmaceuticals Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize Its Drug Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2783614</guid>
      <description><![CDATA[Accentia Biopharmaceuticals, Inc. (Pink Sheets:ABPI) today announced that the Company and its subsidiaries have filed voluntary petitions for reorganization. With existing cash flows from subsidiaries and the potential for relatively near-term significant business development opportunities, this action is intended to provide an opportunity for the Company to restore shareholder value and to pay secured and unsecured creditors. Under protection of the court, Accentia plans to implement a series of initiatives designed to significantly decrease operating expenses and financing costs, and focus cash and resources on drug development and other priority programs that will allow the Company to attract key funding/partnering opportunities. Affiliates of the Company, including Hopkins Capital Group, LLC, a major shareholder, have indicated a willingness to provide additional financing to the Company as part of its reorganization plan. A conference call and webcast is scheduled for 4:30 p.m. (EST) this afternoon to further discuss this action.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2783614>[More...]</a>]]></description>
      <pubDate>Mon, 10 Nov 2008 15:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2783614</link>
    </item>
    <item>
      <title>Accentia Biopharmaceuticals Announces Pending Delisting from NASDAQ</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2762975</guid>
      <description><![CDATA[Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that the Company elected not to appeal the NASDAQ Stock Market’s Staff determination to delist Accentia’s shares of common stock from the NASDAQ Capital Market. As previously reported, Accentia received notice from the NASDAQ Stock Market dated October 24, 2008, notifying the Company that it is not in compliance with Rule 4310(c)(3)(B), requiring a minimum $35 million market value. As a result, at the opening of business on November 4, 2008, shares of Accentia will open for trading listed on the Pink Sheets, an electronic quotation service for securities traded over-the-counter. Accentia’s stock ticker symbol will remain the same (“ABPI”).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2762975>[More...]</a>]]></description>
      <pubDate>Mon, 03 Nov 2008 20:19:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2762975</link>
    </item>
    <item>
      <title>Biovest and IDIS Announce Agreement to Launch Named-Patient Program for Anti-Cancer Vaccine in Europe</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2747992</guid>
      <description><![CDATA[Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), today announced that it has executed a distribution agreement with IDIS Limited to exclusively supply BiovaxID&#174; (personalized, anti-idiotype cancer vaccine) under a Named-Patient Program in France, Germany, Italy, Greece, Spain and the United Kingdom. IDIS is a leading European drug distributor, and under terms of this agreement, sales of BiovaxID are expected to commence in the first calendar quarter of 2009, with the anti-cancer vaccine being made available to those patients suffering from various B-cell related blood cancers including: chronic lymphocytic leukemia; mantle cell lymphoma; multiple myeloma; and non-Hodgkin’s lymphoma.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2747992>[More...]</a>]]></description>
      <pubDate>Wed, 29 Oct 2008 13:27:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2747992</link>
    </item>
    <item>
      <title>Accentia Biopharmaceuticals to Present at Rodman &amp; Renshaw 10th Annual Healthcare Conference; Company Also Reports On NASDAQ Compliance Plan</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2737290</guid>
      <description><![CDATA[Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that it will present at the Rodman &amp; Renshaw 10th Annual Healthcare Conference on November 11, 2008 at 10:20 a.m. (EDT) at the New York Palace Hotel in New York City. The Company’s presentation will focus on its BiovaxID&#174; personalized anti-cancer vaccine. Accentia’s majority-owned subsidiary, Biovest International, Inc. (OTCBB:BVTI), recently reported encouraging BiovaxID Phase 3 clinical trial results for the treatment of non-Hodgkin’s lymphoma, and the Company is now progressing with plans to seek approvals in the U.S., Europe and other international countries.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2737290>[More...]</a>]]></description>
      <pubDate>Fri, 24 Oct 2008 21:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2737290</link>
    </item>
    <item>
      <title>Biovest Announces $1.6M in Federal Funding Appropriated for Groundbreaking Cancer Vaccine &amp; Skin/Bone/Tissue Repair Research</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2729980</guid>
      <description><![CDATA[Biovest International, Inc. (OTCBB:BVTI) today announced that the U.S. Federal Government has approved the appropriation of $1.6 million in biomedical research funds for Fiscal Year 2009 for the Defense Department's Cancer Immunotherapy and Cell Therapy Initiative, which is intended to support research into new applications for the AutovaxID™ instrument, Biovest's fully-automated cell-manufacturing device to cost-effectively and efficiently manufacture difficult-to-produce therapeutic proteins and personalized vaccines, including vaccines targeting cancers.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2729980>[More...]</a>]]></description>
      <pubDate>Wed, 22 Oct 2008 18:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2729980</link>
    </item>
    <item>
      <title>Form  4          OSMAN RONALD E            For: May 22 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3245005</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3245005>[More...]</a>]]></description>
      <pubDate>Tue, 26 May 2009 22:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3245005</link>
    </item>
    <item>
      <title>Form  4          BIOVEST INTERNATIONAL     For: Oct 06  Filed by: OSMAN RONALD E (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2684323</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2684323>[More...]</a>]]></description>
      <pubDate>Mon, 06 Oct 2008 22:20:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2684323</link>
    </item>
    <item>
      <title>Form  4          BIOVEST INTERNATIONAL     For: Sep 26  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2665222</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2665222>[More...]</a>]]></description>
      <pubDate>Tue, 30 Sep 2008 22:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2665222</link>
    </item>
    <item>
      <title>Form  4          OSMAN RONALD E            For: Sep 18 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2629094</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2629094>[More...]</a>]]></description>
      <pubDate>Thu, 18 Sep 2008 15:21:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2629094</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 11  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2508735</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2508735>[More...]</a>]]></description>
      <pubDate>Wed, 13 Aug 2008 13:02:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2508735</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 08  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2498513</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2498513>[More...]</a>]]></description>
      <pubDate>Mon, 11 Aug 2008 12:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2498513</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 06  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2487702</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2487702>[More...]</a>]]></description>
      <pubDate>Thu, 07 Aug 2008 12:32:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2487702</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 05  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2481776</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2481776>[More...]</a>]]></description>
      <pubDate>Wed, 06 Aug 2008 12:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2481776</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 04  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2476366</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2476366>[More...]</a>]]></description>
      <pubDate>Tue, 05 Aug 2008 14:23:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2476366</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Jul 31  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2464843</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2464843>[More...]</a>]]></description>
      <pubDate>Fri, 01 Aug 2008 19:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2464843</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ABPI,BVTI," rel="self" type="application/rss+xml" />
  </channel>
</rss>